DK175528B1 - Vaccine med E.coli septicaemia hos fjerkræ - Google Patents

Vaccine med E.coli septicaemia hos fjerkræ Download PDF

Info

Publication number
DK175528B1
DK175528B1 DK198805934A DK593488A DK175528B1 DK 175528 B1 DK175528 B1 DK 175528B1 DK 198805934 A DK198805934 A DK 198805934A DK 593488 A DK593488 A DK 593488A DK 175528 B1 DK175528 B1 DK 175528B1
Authority
DK
Denmark
Prior art keywords
fimbries
vaccine
coli
immunogenic
fimbri
Prior art date
Application number
DK198805934A
Other languages
Danish (da)
English (en)
Other versions
DK593488A (da
DK593488D0 (da
Inventor
Johannes Franciscus Van Bosch
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of DK593488D0 publication Critical patent/DK593488D0/da
Publication of DK593488A publication Critical patent/DK593488A/da
Application granted granted Critical
Publication of DK175528B1 publication Critical patent/DK175528B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK198805934A 1987-10-26 1988-10-25 Vaccine med E.coli septicaemia hos fjerkræ DK175528B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8702536 1987-10-26
NL8702536 1987-10-26

Publications (3)

Publication Number Publication Date
DK593488D0 DK593488D0 (da) 1988-10-25
DK593488A DK593488A (da) 1989-04-27
DK175528B1 true DK175528B1 (da) 2004-11-22

Family

ID=19850813

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198805934A DK175528B1 (da) 1987-10-26 1988-10-25 Vaccine med E.coli septicaemia hos fjerkræ

Country Status (19)

Country Link
US (2) US5208024A (es)
EP (1) EP0314224B1 (es)
JP (1) JP2718523B2 (es)
KR (1) KR970005333B1 (es)
CN (1) CN1038559C (es)
AR (1) AR241634A1 (es)
AU (1) AU610940B2 (es)
CA (1) CA1331445C (es)
DD (1) DD283331A5 (es)
DE (1) DE3871489D1 (es)
DK (1) DK175528B1 (es)
ES (1) ES2042718T3 (es)
GR (1) GR3005517T3 (es)
HU (1) HU203673B (es)
IE (1) IE60324B1 (es)
NZ (1) NZ226677A (es)
PT (1) PT88850B (es)
YU (1) YU47473B (es)
ZA (1) ZA887694B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830709A (en) * 1989-10-27 1998-11-03 Benson; Roger E. Detection method for homologous portions of a class of substances
ZA934199B (en) * 1992-06-18 1994-01-10 Akzo Nv Carrier system against gnrh
AU5715194A (en) * 1992-12-04 1994-07-04 N.V. Innogenetics S.A. New polypeptides, nucleic acid sequences encoding them, and their use to prevent the adhesion of f107-fimbriated bacteria
US5403582A (en) * 1993-01-21 1995-04-04 Nippon Zeon Co., Ltd. Vaccine comprising fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus
WO1996000233A1 (en) * 1994-06-24 1996-01-04 Children's Hospital And Medical Center Escherichia coli o157:h7 epithelial adhesin
US5914114A (en) * 1995-06-02 1999-06-22 The United States Of America As Represented By The Secretary Of The Army Method of raising antibodies against E. coli of the family CS4-CFA/I
US6399074B1 (en) 1998-07-24 2002-06-04 Megan Health, Inc. Live attenuated salmonella vaccines to control avian pathogens
DE10203652B4 (de) * 2002-01-30 2006-10-19 Westfalia Separator Ag Vollmantel-Schneckenzentrifuge mit einem Wehr
CN101948538A (zh) * 2010-10-19 2011-01-19 郑州后羿制药有限公司 一种抗大肠杆菌的鸡卵黄抗体精制方法
US8926980B2 (en) * 2011-07-11 2015-01-06 Camas Incorporated Compositions against bacterial toxins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982003088A1 (en) * 1981-03-09 1982-09-16 Corp Cetus Vaccines
JPS58131920A (ja) * 1982-01-29 1983-08-06 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
JPS58146596A (ja) * 1982-02-25 1983-09-01 Takeda Chem Ind Ltd 組換えｄｎａ、それで形質転換させた微生物およびそれらの用途
WO1984003506A1 (en) * 1983-03-08 1984-09-13 Commw Serum Lab Commission Antigenically active amino acid sequences
US4736017A (en) * 1984-04-30 1988-04-05 The Board Of Trustees Of The Leland Stanford Junior University Chemically defined vaccine against urinary infections
US4740585A (en) * 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
ES8705033A1 (es) * 1984-12-04 1987-04-16 Biotech Australia Pty Ltd Un metodo para preparar una vacuna para uso en el tratamiento prevencion de diarrea porcina neonatol.
DK41885A (da) * 1985-01-31 1986-11-13 Slagteriernes Forskningsinst 987p-fimbrie-producerende mikroorganisme, vaccine til immunisering af grise samt fremgangsmaade til fremstilling af vaccinen
US4725435A (en) * 1986-06-18 1988-02-16 Bactex, Inc. Vaccine composition for immunization against urinary tract infection caused by E. coli
DE69016129T2 (de) * 1989-08-18 1995-05-24 Akzo Nobel Nv Vakzin gegen Escherichia coli.

Also Published As

Publication number Publication date
IE60324B1 (en) 1994-06-29
KR890006253A (ko) 1989-06-12
JP2718523B2 (ja) 1998-02-25
DD283331A5 (de) 1990-10-10
IE883130L (en) 1989-04-26
DK593488A (da) 1989-04-27
PT88850B (pt) 1993-01-29
CN1033008A (zh) 1989-05-24
HUT48122A (en) 1989-05-29
US5208024A (en) 1993-05-04
JPH01149734A (ja) 1989-06-12
CA1331445C (en) 1994-08-16
US5593679A (en) 1997-01-14
AU610940B2 (en) 1991-05-30
HU203673B (en) 1991-09-30
NZ226677A (en) 1990-09-26
GR3005517T3 (es) 1993-06-07
KR970005333B1 (ko) 1997-04-15
YU47473B (sh) 1995-10-03
EP0314224B1 (en) 1992-05-27
DK593488D0 (da) 1988-10-25
CN1038559C (zh) 1998-06-03
DE3871489D1 (de) 1992-07-02
AU2432988A (en) 1989-04-27
ES2042718T3 (es) 1993-12-16
YU193688A (en) 1990-06-30
EP0314224A1 (en) 1989-05-03
AR241634A1 (es) 1992-10-30
ZA887694B (en) 1989-06-28

Similar Documents

Publication Publication Date Title
de Zoete et al. Vaccination of chickens against Campylobacter
AU2004279610B2 (en) Piscirickettsia salmonis antigens and use thereof
DK175528B1 (da) Vaccine med E.coli septicaemia hos fjerkræ
CN113943714A (zh) 一种猫杯状病毒毒株及其应用
EP1885401B1 (en) Anti-adhesin based passive immunoprophylactic against enterotoxigenic escherichia coli
EP2029166A2 (en) Vaccination of young animals against lawsonia intracellularis infections
BRPI0621760A2 (pt) molécula de ácido nucléico recombinante que não ocorre naturalmente, célula recombinante, composição imunogênica, anticorpo, método para detectar a presença de proteìna pilus de campylobacter e método para detectar um anticorpo que se liga especificamente a uma proteìna pilus de campylobacter jejuni
CN100412092C (zh) 一种抗大肠杆菌的鸡卵黄抗体及其制备方法与应用
CN113754782A (zh) 一种幽门螺旋杆菌卵黄抗体及其制备方法和应用
AU775752B2 (en) Campylobacter vaccine
Vandemaele et al. Immunization with the biologically active lectin domain of PapGII induces strong adhesion-inhibiting antibody responses but not protection against avian pathogenic Escherichia coli
Yousif et al. Oral administration of hyperimmune IgY: an immunoecological approach to curbing acute infectious bursal disease virus infection
Nathanson et al. Cyclophosphamide-induced immunosuppression demonstrated in Pasteurella multocida-vaccinated chickens
EP1043029A1 (en) Campylobacter vaccine
RU2683027C2 (ru) Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию
CA2141475C (en) Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof
CN105367659A (zh) 一种抑制脲酶活性卵黄抗体的制备方法及应用
Senyk et al. Cell-mediated immune responses to chlamydial antigens in guinea pigs injected with inactivated chlamydiae
US20030149255A1 (en) Bird diagnostics and treatments
RU2213576C1 (ru) Способ изготовления инактивированной эмульсионной вакцины против синдрома гидроперикардита кур
Elsheikha et al. Therapeutic efficacy of chicken egg yolk immunoglobulins against Mycoplasma gallisepticum infection in chickens
CN111825774A (zh) 一种猪致病性大肠杆菌双价ltb毒素及制备工艺和应用
CA2615139A1 (en) Piscirickettsia salmonis antigens and use thereof
Badran Trials for control of edwardsiellosis by immersion vaccination (A) immersion vaccination of Nile tilapia (Oreochromis niloticus) with Edwardsiella tarda crude lipopolysaccharide.
Yang et al. Protective efficacy of a genetic subunit bacterin against edema disease of swine in mice

Legal Events

Date Code Title Description
PUP Patent expired